Asset Details
Do you wish to reserve the book?
EQ-5D and the EuroQol Group: Past, Present and Future
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
EQ-5D and the EuroQol Group: Past, Present and Future
Do you wish to request the book?
EQ-5D and the EuroQol Group: Past, Present and Future
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
EQ-5D and the EuroQol Group: Past, Present and Future
2017
Overview
Over the period 1987–1991 an inter-disciplinary five-country group developed the EuroQol instrument, a five-dimensional three-level generic measure subsequently termed the ‘EQ-5D’. It was designed to measure and value health status. The salient features of its development and its consolidation and expansion are discussed. Initial expansion came, in particular, in the form of new language versions. Their development raised translation and semantic issues, experience with which helped feed into the design of two further instruments, the EQ-5D-5L and the youth version EQ-5D-Y. The expanded usage across clinical programmes, disease and condition areas, population surveys, patient-reported outcomes, and value sets is outlined. Valuation has been of continued relevance for the Group as this has allowed its instruments to be utilised as part of the economic appraisal of health programmes and their incorporation into health technology assessments. The future of the Group is considered in the context of: (1) its scientific strategy, (2) changes in the external environment affecting the demand for EQ-5D, and (3) a variety of issues it is facing in the context of the design of the instrument, its use in health technology assessment, and potential new uses for EQ-5D outside of clinical trials and technology appraisal.
Publisher
Springer International Publishing,Springer Nature B.V
Subject
/ Delivery of Health Care - organization & administration
/ Delivery of Health Care - standards
/ Delivery of Health Care - trends
/ Europe
/ Groups
/ Health technology assessment
/ Humans
/ Measures
/ Medicine
/ Patients
/ Pharmacoeconomics and Health Outcomes
/ Quality Assurance, Health Care - methods
/ Quality Assurance, Health Care - organization & administration
/ Quality Assurance, Health Care - standards
/ Quality Assurance, Health Care - trends
/ Quality Indicators, Health Care - organization & administration
/ Quality Indicators, Health Care - standards
/ R&D
/ Review
/ Value
/ Youth
